Abstract:Ecoinfectomics is the ecological study of infectomes and explores symbiotic solutions to microbial infections. The most fundamental issue in ecological infectomics is how to transform situations of potential conflict (pathogenesis or Pat) into cooperation (symbiosis or Sym) by dissecting the dynamic Sym-Pat duality in microbial infections and developing symbiotic agents (symbiotics) that favor a healthy symbiosis. Symbiotics are defined as products that are beneficial to the symbiotic ecology of the super-organisms consisting of microbes and their human hosts. These include microbial (e.g., probiotic bacteria and phages) and nonmicrobial agents (e.g., prebiotics). Probiotics have been proposed as a promising way to prevent microbial infection in neonates. It has been shown that probiotics could be useful to correct ecological disorders in human intestinal microbiota associated with neonatal sepsis and meningitis, and might play a protective role in excluding pathogens from the intestine and preventing infections. Compared with commonly used antibiotics, a great advantage of phages is their narrow host range. A rational basis has been provided for the discovery and development of phage-based symbiotics that only kill pathogens but do not disturb benign microbes in normal microbiota. The systems biology study of ecoimmunity or ecoimmunome (ecoimmunomics), which is most closely related to ecoinfectomics, may provide alternative ecological strategies toward clinical challenges in infectious diseases. We propose that the balance between exosymbiosis (e.g, microbiota) and endosymbiosis (e.g., mitochondria) is essential for ecoimmunity and that the exo-endo Sym imbalance plays an important role in the pathogenesis of infectious diseases, including HIV/AIDS. Correction of disorders of the ecoimmunity in patients with AIDS may lead to a rational control of HIV infection. Holistic and integrative studies of ecoinfectomes, ecoimmunomes, and microbiome are important for our understanding of microbial pathogenesis and the development of symbiotic solutions to infectious diseases. © 2013 Bentham Science Publishers.

Exploring Novel Immunological Interventions Using Immunoinfectomics

Infectomics in the Discovery and Development of New Antimicrobial Agents

Infectomics: the Global and Integrative Study of Infectious Diseases

Infectomics Screening for Novel Antiviral Drug Targets

Vaccines and Immunoinformatics for Vaccine Design.

Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19

Immunomic Approaches for Antigen Discovery of Human Parasites

Infectomics: genomics and proteomics of microbial infections

Chemoinfectomics in Drug Design and Development

Solving Immunology?

Vaccinomics: a future avenue for vaccine development against emerging pathogens

INFECTOMICS IN THE EXPLOITATION OF NEW ANTIINFECTIVE AGENTS

Ecological infectomics (ecoinfectomics): Symbiotic solutions to microbial infections

The Clinical Applications of Immunosequencing

Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector Proteins.

Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens

Application of Advanced Bioimaging Technologies in Viral Infections

Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents

Advancements in Immunology and Microbiology Research: A Comprehensive Exploration of Key Areas

Research progress and applications of nanobody in human infectious diseases

Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases